Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Dis Model Mech
2009 Jan 01;27-8:374-88. doi: 10.1242/dmm.001008.
Show Gene links
Show Anatomy links
Muscular dystrophy begins early in embryonic development deriving from stem cell loss and disrupted skeletal muscle formation.
Merrick D
,
Stadler LK
,
Larner D
,
Smith J
.
???displayArticle.abstract???
Examination of embryonic myogenesis of two distinct, but functionally related, skeletal muscle dystrophy mutants (mdx and cav-3(-/-)) establishes for the first time that key elements of the pathology of Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophy type 1C (LGMD-1c) originate in the disruption of the embryonic cardiac and skeletal muscle patterning processes. Disruption of myogenesis occurs earlier in mdx mutants, which lack a functional form of dystrophin, than in cav-3(-/-) mutants, which lack the Cav3 gene that encodes the protein caveolin-3; this finding is consistent with the milder phenotype of LGMD-1c, a condition caused by mutations in Cav3, and the earlier [embryonic day (E)9.5] expression of dystrophin. Myogenesis is severely disrupted in mdx embryos, which display developmental delays; myotube morphology and displacement defects; and aberrant stem cell behaviour. In addition, the caveolin-3 protein is elevated in mdx embryos. Both cav-3(-/-) and mdx mutants (from E15.5 and E11.5, respectively) exhibit hyperproliferation and apoptosis of Myf5-positive embryonic myoblasts; attrition of Pax7-positive myoblasts in situ; and depletion of total Pax7 protein in late gestation. Furthermore, both cav-3(-/-) and mdx mutants have cardiac defects. In cav-3(-/-) mutants, there is a more restricted phenotype comprising hypaxial muscle defects, an excess of malformed hypertrophic myotubes, a twofold increase in myonuclei, and reduced fast myosin heavy chain (FMyHC) content. Several mdx mutant embryo pathologies, including myotube hypotrophy, reduced myotube numbers and increased FMyHC, have reciprocity with cav-3(-/-) mutants. In double mutant (mdxcav-3(+/-)) embryos that are deficient in dystrophin (mdx) and heterozygous for caveolin-3 (cav-3(+/-)), whereby caveolin-3 is reduced to 50% of wild-type (WT) levels, these phenotypes are severely exacerbated: intercostal muscle fibre density is reduced by 71%, and Pax7-positive cells are depleted entirely from the lower limbs and severely attenuated elsewhere; these data suggest a compensatory rather than a contributory role for the elevated caveolin-3 levels that are found in mdx embryos. These data establish a key role for dystrophin in early muscle formation and demonstrate that caveolin-3 and dystrophin are essential for correct fibre-type specification and emergent stem cell function. These data plug a significant gap in the natural history of muscular dystrophy and will be invaluable in establishing an earlier diagnosis for DMD/LGMD and in designing earlier treatment protocols, leading to better clinical outcome for these patients.
???displayArticle.pubmedLink???
19535499
???displayArticle.pmcLink???PMC2707105 ???displayArticle.link???Dis Model Mech ???displayArticle.grants???[+]
Agbulut,
Myosin heavy chain isoforms in postnatal muscle development of mice.
2003, Pubmed
Agbulut,
Myosin heavy chain isoforms in postnatal muscle development of mice.
2003,
Pubmed
Anderson,
Dystroglycan protein distribution coincides with basement membranes and muscle differentiation during mouse embryogenesis.
2007,
Pubmed
Aravamudan,
Transgenic overexpression of caveolin-3 in the heart induces a cardiomyopathic phenotype.
2003,
Pubmed
Armand,
Origin of satellite cells in avian skeletal muscles.
1983,
Pubmed
Baghdiguian,
Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IkappaB alpha/NF-kappaB pathway in limb-girdle muscular dystrophy type 2A.
1999,
Pubmed
Bassett,
Dystrophin is required for the formation of stable muscle attachments in the zebrafish embryo.
2003,
Pubmed
Biederer,
The basic helix-loop-helix transcription factors myogenin and Id2 mediate specific induction of caveolin-3 gene expression during embryonic development.
2000,
Pubmed
Chamberlain,
Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma.
2007,
Pubmed
Chan,
Branched fibers in dystrophic mdx muscle are associated with a loss of force following lengthening contractions.
2007,
Pubmed
Cho,
Fast myosin heavy chains expressed in secondary mammalian muscle fibers at the time of their inception.
1994,
Pubmed
Cossu,
How is myogenesis initiated in the embryo?
1996,
Pubmed
Cox,
Dystrophies and heart disease.
1997,
Pubmed
Cuda,
Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy.
1993,
Pubmed
Cusella-De Angelis,
MyoD, myogenin independent differentiation of primordial myoblasts in mouse somites.
1992,
Pubmed
Ervasti,
A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin.
1993,
Pubmed
,
Xenbase
Finsterer,
Left ventricular hypertrabeculation/noncompaction as a cardiac manifestation of Duchenne muscular dystrophy under non-invasive positive-pressure ventilation.
2005,
Pubmed
Frock,
Lamin A/C and emerin are critical for skeletal muscle satellite cell differentiation.
2006,
Pubmed
Galbiati,
Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype.
2000,
Pubmed
Galbiati,
Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and t-tubule abnormalities.
2001,
Pubmed
Geisterfer-Lowrance,
A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation.
1990,
Pubmed
Glass,
A signaling role for dystrophin: inhibiting skeletal muscle atrophy pathways.
2005,
Pubmed
Gros,
A two-step mechanism for myotome formation in chick.
2004,
Pubmed
Gross,
Lbx1 is required for muscle precursor migration along a lateral pathway into the limb.
2000,
Pubmed
Hadchouel,
Analysis of a key regulatory region upstream of the Myf5 gene reveals multiple phases of myogenesis, orchestrated at each site by a combination of elements dispersed throughout the locus.
2003,
Pubmed
Hagiwara,
Caveolin-3 deficiency causes muscle degeneration in mice.
2000,
Pubmed
Harper,
Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy.
2002,
Pubmed
Hayashi,
Identification and functional analysis of a caveolin-3 mutation associated with familial hypertrophic cardiomyopathy.
2004,
Pubmed
Hoffman,
Dystrophin: the protein product of the Duchenne muscular dystrophy locus.
1987,
Pubmed
Hollway,
Myotome meanderings. Cellular morphogenesis and the making of muscle.
2003,
Pubmed
Houzelstein,
Localization of dystrophin gene transcripts during mouse embryogenesis.
1992,
Pubmed
Huang,
Structure of a WW domain containing fragment of dystrophin in complex with beta-dystroglycan.
2000,
Pubmed
Ilsley,
The WW domain: linking cell signalling to the membrane cytoskeleton.
2002,
Pubmed
Jung,
Identification and characterization of the dystrophin anchoring site on beta-dystroglycan.
1995,
Pubmed
Lehmann,
Cell migration in invertebrates: clues from border and distal tip cells.
2001,
Pubmed
Lindon,
Cell cycle-regulated expression of the muscle determination factor Myf5 in proliferating myoblasts.
1998,
Pubmed
Merrick,
A role for Insulin-like growth factor 2 in specification of the fast skeletal muscle fibre.
2007,
Pubmed
Minetti,
Impairment of caveolae formation and T-system disorganization in human muscular dystrophy with caveolin-3 deficiency.
2002,
Pubmed
Nixon,
Zebrafish as a model for caveolin-associated muscle disease; caveolin-3 is required for myofibril organization and muscle cell patterning.
2005,
Pubmed
Ohlendieck,
Duchenne muscular dystrophy: deficiency of dystrophin-associated proteins in the sarcolemma.
1993,
Pubmed
Ott,
Early expression of the myogenic regulatory gene, myf-5, in precursor cells of skeletal muscle in the mouse embryo.
1991,
Pubmed
Oustanina,
Pax7 directs postnatal renewal and propagation of myogenic satellite cells but not their specification.
2004,
Pubmed
Parsons,
Removal of dystroglycan causes severe muscular dystrophy in zebrafish embryos.
2002,
Pubmed
Quinlan,
Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings.
2004,
Pubmed
Razani,
Molecular cloning and developmental expression of the caveolin gene family in the amphibian Xenopus laevis.
2002,
Pubmed
,
Xenbase
Reimann,
Regenerative capacity and the number of satellite cells in soleus muscles of normal and mdx mice.
2000,
Pubmed
Relaix,
Pax3 and Pax7 have distinct and overlapping functions in adult muscle progenitor cells.
2006,
Pubmed
Roig,
Longitudinal pathologic study of the gastrocnemius muscle group in mdx mice.
2004,
Pubmed
Roma,
Evolution of pathological changes in the gastrocnemius of the mdx mice correlate with utrophin and beta-dystroglycan expression.
2004,
Pubmed
Schofield,
Expression of the dystrophin-related protein (utrophin) gene during mouse embryogenesis.
1993,
Pubmed
Schofield,
Dystroglycan mRNA expression during normal and mdx mouse embryogenesis: a comparison with utrophin and the apo-dystrophins.
1995,
Pubmed
Seale,
Pax7 is required for the specification of myogenic satellite cells.
2000,
Pubmed
Shin,
Caveolin-3 expression during early chicken development.
2003,
Pubmed
Smith,
Embryonic skeletal muscle microexplant culture and isolation of skeletal muscle stem cells.
2010,
Pubmed
Smith,
Programmed cell death in dystrophic (mdx) muscle is inhibited by IGF-II.
1995,
Pubmed
Smith,
IGF-II ameliorates the dystrophic phenotype and coordinately down-regulates programmed cell death.
2000,
Pubmed
Smith,
Stable integration of an mdx skeletal muscle cell line into dystrophic (mdx) skeletal muscle: evidence for stem cell status.
1997,
Pubmed
Smith,
The effects of fibroblast growth factors in long-term primary culture of dystrophic (mdx) mouse muscle myoblasts.
1994,
Pubmed
Smythe,
A caveolin-3 mutant that causes limb girdle muscular dystrophy type 1C disrupts Src localization and activity and induces apoptosis in skeletal myotubes.
2003,
Pubmed
Sotgia,
Caveolin-3 directly interacts with the C-terminal tail of beta -dystroglycan. Identification of a central WW-like domain within caveolin family members.
2000,
Pubmed
Spencer,
Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity.
1997,
Pubmed
Vaghy,
Increased caveolin-3 levels in mdx mouse muscles.
1998,
Pubmed
Volonte,
Modulation of myoblast fusion by caveolin-3 in dystrophic skeletal muscle cells: implications for Duchenne muscular dystrophy and limb-girdle muscular dystrophy-1C.
2003,
Pubmed
Webster,
Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy.
1988,
Pubmed
Weir,
A-utrophin up-regulation in mdx skeletal muscle is independent of regeneration.
2004,
Pubmed
Wilding,
Dystrophin- and MLP-deficient mouse hearts: marked differences in morphology and function, but similar accumulation of cytoskeletal proteins.
2005,
Pubmed
Williamson,
Dystroglycan is essential for early embryonic development: disruption of Reichert's membrane in Dag1-null mice.
1997,
Pubmed
Woodman,
Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade.
2002,
Pubmed
Yue,
Microdystrophin gene therapy of cardiomyopathy restores dystrophin-glycoprotein complex and improves sarcolemma integrity in the mdx mouse heart.
2003,
Pubmed
Zammit,
The skeletal muscle satellite cell: the stem cell that came in from the cold.
2006,
Pubmed
